What is the current Price Target for the Salarius Pharmaceuticals Inc stock?

The average Salarius Pharmaceuticals Inc target price is $26.52. This is 548.41% higher than the current stock price. The highest price target is 567.48%, the lowest is 542.05%. 3 Analysts have issued a price target Salarius Pharmaceuticals Inc 2026 .

How high will the Salarius Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Salarius Pharmaceuticals Inc stock will rise. The performance of stocks, including the Salarius Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Salarius Pharmaceuticals Inc stock today?

The performance of Salarius Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Salarius Pharmaceuticals Inc stock fall?

The decline in Salarius Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Salarius Pharmaceuticals Inc Forecast, price target & analysts

$4.04

1.14% today

Nasdaq, Sep 25, 05:44 pm CET

ISIN

US79400X1072

Symbol

SLRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Salarius Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Salarius Pharmaceuticals Inc Classifications & Recommendation:

Hold

50%

Sell

50%

Salarius Pharmaceuticals Inc Price Target

Target Price	$26.52
Price	$4.09
Potential	548.41% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Salarius Pharmaceuticals Inc 2026 . The average Salarius Pharmaceuticals Inc target price is $26.52. This is 548.41% register free of charge higher than the current stock price. The highest price target is $27.30 567.48% register free of charge , the lowest is $26.26 542.05% register free of charge .
	A rating was issued by 6 analysts: 0 Analysts recommend Salarius Pharmaceuticals Inc to buy, 3 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Salarius Pharmaceuticals Inc stock has an average upside potential 2026 of 548.41% register free of charge . Most analysts recommend the Salarius Pharmaceuticals Inc stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-86.91	-9.35
	81.15%	89.24%
P/E		negative

3 Analysts have issued a Salarius Pharmaceuticals Inc forecast for earnings per share. The average Salarius Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-86.91	81.15%
2025	$-9.35 89.24% Unlock

Current	-0.11	28.57%
2025	-0.44 287.67% Unlock

Salarius Pharmaceuticals Inc...

Discover more stocks with a high price target

Novo Nordisk 41.24%

TUI 41.10%

BioNTech SE - ADR 40.09%

Deutsche Telekom 35.71%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now